Catalyst Wire Dossier Catalyst Wire Dossier

AHZANTIVE

AFLIBERCEPT-MRBB · Valorum Biologics, LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AHZANTIVE, covering 2024-06-28 to 2025-11-07. Get the full timeline:

Most recent: EMA Authorised: Ahzantive (aflibercept) — Formycon AG

See pricing